Evidence map›Paper›PMID 24894124›Full record

ArticleJournal of visualized experiments : JoVE2014

Application of retinoic acid to obtain osteocytes cultures from primary mouse osteoblasts.

Deborah Mattinzoli, Piergiorgio Messa, Alessandro Corbelli, Masami Ikehata, Anna Mondini, Cristina Zennaro, Silvia Armelloni, Min Li, Laura Giardino, Maria Pia Rastaldi

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Targeted silencing ofFrontiers in endocrinology · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation.International journal of molecular sciences · 2019
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Deborah MattinzoliRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Piergiorgio MessaDepartment of Nephrology, Dialysis and Renal Transplant, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Alessandro CorbelliRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Masami IkehataRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Anna MondiniRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Cristina ZennaroRenal Physiopathology Laboratory, Department of Medical, Surgical and Health Sciences, University of Trieste.
Silvia ArmelloniRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Min LiRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Laura GiardinoRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.
Maria Pia RastaldiRenal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; mariapia.rastaldi@policlinico.mi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for osteocyte cultures is well known to the community of bone researchers; isolation of primary osteocytes is difficult and produces low cell numbers. Therefore, the most widely used cellular system is the osteocyte-like MLO-Y4 cell line. The method here described refers to the use of retinoic acid to generate a homogeneous population of ramified cells with morphological and molecular osteocyte features. After isolation of osteoblasts from mouse calvaria, all-trans retinoic acid (ATRA) is added to cell medium, and cell monitoring is conducted daily under an inverted microscope. First morphological changes are detectable after 2 days of treatment and differentiation is generally complete in 5 days, with progressive development of dendrites, loss of the ability to produce extracellular matrix, down-regulation of osteoblast markers and up-regulation of osteocyte-specific molecules. Daily cell monitoring is needed because of the inherent variability of primary cells, and the protocol can be adapted with minimal variation to cells obtained from different mouse strains and applied to transgenic models. The method is easy to perform and does not require special instrumentation, it is highly reproducible, and rapidly generates a mature osteocyte population in complete absence of extracellular matrix, allowing the use of these cells for unlimited biological applications.

Indexed as

AnimalsCell Culture TechniquesCulture MediaMiceMice, TransgenicOsteoblastsOsteocytesTretinoinCulture MediaTretinoin

Identifiers

PMID24894124
PMCPMC4186284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.